Breakthrough Designation: Drugmakers Cheer 'Speed Lane' For FDA Approval
Category: WELLNESS
In the 1990s, she said, the agency was not seeing drugs whose promise could be detected in early clinical trials. J&J's ibrutinib
By Reuters, Reuters, 2013-07-24